AI assistant
Sending…
GENTEX CORP — Director's Dealing 2023
Aug 1, 2023
30893_dirs_2023-08-01_ff0d6f85-a7fc-4bc3-b488-20782047f18a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2023-07-31
Reporting Person: Starkoff Kathleen (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-07-31 | Common Stock | M | 4430.00 | $21.46 | Acquired | 25871.00 | Direct |
| 2023-07-31 | Common Stock | S | 4430.00 | $33.2041 | Disposed | 21441.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-07-31 | Non-Employee Director Stock Option Grant | $21.46 | M | 4430.00 | Disposed | 2028-09-28 | Common Stock (4430.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $33.20 to $33.215. The price reported above reflects the weighted average price.
More from GENTEX CORP
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19